Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmelé T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA.

Crit Care. 2013 Feb 6;17(1):R25. doi: 10.1186/cc12503.

2.

Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.

Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, Fitzgerald R, Gong MN, Graham DD, Gunnerson K, Heung M, Jortani S, Kleerup E, Koyner JL, Krell K, Letourneau J, Lissauer M, Miner J, Nguyen HB, Ortega LM, Self WH, Sellman R, Shi J, Straseski J, Szalados JE, Wilber ST, Walker MG, Wilson J, Wunderink R, Zimmerman J, Kellum JA.

Am J Respir Crit Care Med. 2014 Apr 15;189(8):932-9. doi: 10.1164/rccm.201401-0077OC.

PMID:
24559465
3.

Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.

Dusse F, Edayadiyil-Dudásova M, Thielmann M, Wendt D, Kahlert P, Demircioglu E, Jakob H, Schaefer ST, Pilarczyk K.

BMC Anesthesiol. 2016 Sep 8;16:76. doi: 10.1186/s12871-016-0244-8. Erratum in: BMC Anesthesiol. 2016 Oct 3;16(1):82.

4.

Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.

Meersch M, Schmidt C, Van Aken H, Martens S, Rossaint J, Singbartl K, Görlich D, Kellum JA, Zarbock A.

PLoS One. 2014 Mar 27;9(3):e93460. doi: 10.1371/journal.pone.0093460. eCollection 2014.

5.

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.

Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, Feldkamp T, Uettwiller-Geiger DL, McCarthy P, Shi J, Walker MG, Kellum JA; Sapphire Investigators.

Nephrol Dial Transplant. 2014 Nov;29(11):2054-61. doi: 10.1093/ndt/gfu292. Epub 2014 Sep 18.

6.

Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.

Westhoff JH, Tönshoff B, Waldherr S, Pöschl J, Teufel U, Westhoff TH, Fichtner A.

PLoS One. 2015 Nov 25;10(11):e0143628. doi: 10.1371/journal.pone.0143628. eCollection 2015.

7.

Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.

Gocze I, Koch M, Renner P, Zeman F, Graf BM, Dahlke MH, Nerlich M, Schlitt HJ, Kellum JA, Bein T.

PLoS One. 2015 Mar 23;10(3):e0120863. doi: 10.1371/journal.pone.0120863. eCollection 2015.

8.

Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.

Koyner JL, Shaw AD, Chawla LS, Hoste EA, Bihorac A, Kashani K, Haase M, Shi J, Kellum JA; Sapphire Investigators.

J Am Soc Nephrol. 2015 Jul;26(7):1747-54. doi: 10.1681/ASN.2014060556. Epub 2014 Dec 22.

9.

TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients.

Gunnerson KJ, Shaw AD, Chawla LS, Bihorac A, Al-Khafaji A, Kashani K, Lissauer M, Shi J, Walker MG, Kellum JA; Sapphire Topaz investigators.

J Trauma Acute Care Surg. 2016 Feb;80(2):243-9. doi: 10.1097/TA.0000000000000912.

10.

Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI.

Chindarkar NS, Chawla LS, Straseski JA, Jortani SA, Uettwiller-Geiger D, Orr RR, Kellum JA, Fitzgerald RL.

Clin Chim Acta. 2016 Jan 15;452:32-7. doi: 10.1016/j.cca.2015.10.029. Epub 2015 Nov 10.

11.

Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery.

Meersch M, Schmidt C, Van Aken H, Rossaint J, Görlich D, Stege D, Malec E, Januszewska K, Zarbock A.

PLoS One. 2014 Oct 24;9(10):e110865. doi: 10.1371/journal.pone.0110865. eCollection 2014.

12.

Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.

Daubin D, Cristol JP, Dupuy AM, Kuster N, Besnard N, Platon L, Buzançais A, Brunot V, Garnier F, Jonquet O, Klouche K.

PLoS One. 2017 Jan 13;12(1):e0169674. doi: 10.1371/journal.pone.0169674. eCollection 2017.

13.

Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.

Vijayan A, Faubel S, Askenazi DJ, Cerda J, Fissell WH, Heung M, Humphreys BD, Koyner JL, Liu KD, Mour G, Nolin TD, Bihorac A; American Society of Nephrology Acute Kidney Injury Advisory Group.

Am J Kidney Dis. 2016 Jul;68(1):19-28. doi: 10.1053/j.ajkd.2015.12.033. Epub 2016 Mar 4.

14.

Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury.

Bell M, Larsson A, Venge P, Bellomo R, Mårtensson J.

Dis Markers. 2015;2015:158658. doi: 10.1155/2015/158658. Epub 2015 Mar 18.

15.

Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.

Liu KD, Vijayan A, Rosner MH, Shi J, Chawla LS, Kellum JA.

Nephrol Dial Transplant. 2016 Oct;31(10):1641-6. doi: 10.1093/ndt/gfw238. Epub 2016 Jun 23.

16.

The concept of risk and the value of novel markers of acute kidney injury.

Ronco C, Ricci Z.

Crit Care. 2013 Feb 13;17(1):117. doi: 10.1186/cc12488.

17.

Evaluation of biomarkers of cell cycle arrest and inflammation in prediction of dialysis or recovery after kidney transplantation.

Pianta TJ, Peake PW, Pickering JW, Kelleher M, Buckley NA, Endre ZH.

Transpl Int. 2015 Dec;28(12):1392-404. doi: 10.1111/tri.12636. Epub 2015 Jul 28.

18.

The diagnostic accuracy of urinary [TIMP-2]·[IGFBP7] for acute kidney injury in adults: A PRISMA-compliant meta-analysis.

Liu C, Lu X, Mao Z, Kang H, Liu H, Pan L, Hu J, Wang L, Zhou F.

Medicine (Baltimore). 2017 Jul;96(27):e7484. doi: 10.1097/MD.0000000000007484. Review.

19.

Cell-cycle arrest and acute kidney injury: the light and the dark sides.

Kellum JA, Chawla LS.

Nephrol Dial Transplant. 2016 Jan;31(1):16-22. doi: 10.1093/ndt/gfv130. Epub 2015 Jun 4. Review.

20.

Biomarkers of renal function, which and when?

Wasung ME, Chawla LS, Madero M.

Clin Chim Acta. 2015 Jan 1;438:350-7. doi: 10.1016/j.cca.2014.08.039. Epub 2014 Sep 3. Review.

PMID:
25195004

Supplemental Content

Support Center